208538-73-2

  • Product Name:Micafungin sodium
  • Molecular Formula:C56H70N9NaO23S
  • Purity:99%
  • Molecular Weight:1292.26
Inquiry

Product Details:

CasNo: 208538-73-2

Molecular Formula: C56H70N9NaO23S

Appearance: Off-White Solid

Quality Factory Supply Micafungin sodium,Hot Sale 208538-73-2 Low Price

  • Molecular Formula:C56H70N9NaO23S
  • Molecular Weight:1292.26
  • Appearance/Colour:Off-White Solid 
  • PSA:521.35000 
  • LogP:-0.88160 

Micafungin sodium(Cas 208538-73-2) Usage

Description

Micafungin sodium is an antifungal drug belonging to the class of echinocandins. It is available in the form of a light-sensitive, hygroscopic white powder that is freely soluble in water, isotonic sodium chloride solution, and N,N-dimethylformamide. Micafungin works by inhibiting the synthesis of β-(1,3)-D-glucan, an essential component of the fungal cell wall, thereby disrupting fungal growth and replication.

Chemical Properties

Off-White Solid

Uses

Micafungin injection is primarily used to treat various fungal infections, including:

Candidemia: Fungal infection in the bloodstream caused by Candida species.
Acute disseminated candidiasis: Systemic fungal infection affecting multiple organs or systems in the body.
Candida peritonitis and abscess: Fungal infection occurring in the peritoneum (abdominal cavity lining) or forming abscesses in the stomach.
Esophageal candidiasis: Fungal infection affecting the esophagus, the tube that connects the throat to the stomach.

Brand name

Mycamine(Astellas).

InChI:InChI=1/C56H71N9O23S.Na/c1-4-5-6-17-86-32-14-11-28(12-15-32)39-21-33(63-87-39)27-7-9-29(10-8-27)49(75)58-34-20-38(70)52(78)62-54(80)45-46(72)25(2)23-65(45)56(82)43(37(69)22-41(57)71)60-53(79)44(48(74)47(73)30-13-16-36(68)40(18-30)88-89(83,84)85)61-51(77)35-19-31(67)24-64(35)55(81)42(26(3)66)59-50(34)76;/h7-16,18,21,25-26,31,34-35,37-38,42-48,52,66-70,72-74,78H,4-6,17,19-20,22-24H2,1-3H3,(H2,57,71)(H,58,75)(H,59,76)(H,60,79)(H,61,77)(H,62,80)(H,83,84,85);/q;+1/p-1/t25-,26-,31+,34?,35-,37+,38+,42-,43-,44-,45-,46-,47+,48?,52-;/m1./s1

208538-73-2 Relevant articles

A Case of Initially MRSA-Positive Acanthamoeba Keratitis Ultimately Treated Using Topical Micafungin Sodium

H Ohsugi,S Ataka,E Hishida,M Yamaguchi,K Inoue,M Murasawa,S Wada,Y Takahashi,K Yamazaki,K Abe

, Journal of the Eye 09/30/2005

A Case of initially MRSA-positive Acanthamoeba keratitis ultimately treated using topical micafungin sodium .

AN IMPROVED PROCESS FOR THE PREPARATION OF MICAFUNGIN SODIUM

WW Jonathan , R Dipak Kumar

WO2019IB50016

The present invention relates to an improved process for the preparation of Micafungin sodium of a Compound of Formula (I), by treating Micafungin or its base addition salt with longer chain fatty acid sodium salt.

Relevant Products